Comparing survival rates for clusters of depressive symptoms found by Network analysis' community detection algorithms: Results from a prospective population-based study among 9774 cancer survivors from the PROFILES-registry.
anhedonia
cancer
depression
mortality
negative affect
Journal
The British journal of clinical psychology
ISSN: 0144-6657
Titre abrégé: Br J Clin Psychol
Pays: England
ID NLM: 8105533
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
28
07
2023
received:
27
02
2023
accepted:
29
07
2023
medline:
10
10
2023
pubmed:
23
8
2023
entrez:
23
8
2023
Statut:
ppublish
Résumé
Previous studies have shown that depression is associated with mortality in patients with cancer. Depression is however a heterogeneous construct and it may be more helpful to look at different (clusters) of depressive symptoms than to look at depression as a discrete condition. The aim of the present study is to investigate whether clusters of depressive symptoms can be identified using advanced statistics and to investigate how these symptom clusters are associated with all-cause mortality in a large group of patients with cancer. Data from a large population-based cohort study (PROFILES) including various cancer types were used. Eligible patients completed self-report questionnaires (i.e. Fatigue assessment scale, Hospital anxiety and depression scale, EORTC QOL-C30) after diagnosis. Survival status was determined on 31 January 2022. In total, 9744 patients were included. Network analyses combining different community detection algorithms showed that clusters of depressive symptoms could be detected that correspond with motivational anhedonia, consummatory anhedonia and negative affect. Survival analyses using the variables that represented these clusters best showed that motivational and consummatory anhedonia were associated with survival. Even after controlling for clinical and sociodemographic variables items assessing motivational anhedonia were significantly associated with mortality over time. Separate clusters of symptoms that correspond with motivational and consummatory anhedonia and negative affect can be distinguished and anhedonia may be associated with mortality more than negative affect. Looking at particular (clusters of) depressive symptoms may be more informative and clinically relevant than using depression as a single construct (i.e. syndrome).
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
731-747Subventions
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : NWO#480-08-009
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : NWO#451-10-041
Informations de copyright
© 2023 The Authors. British Journal of Clinical Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.
Références
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P. B., Schraub, S., Sneeuw, K., Sullivan, M., & Takeda, F. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8433390
Argyropoulos, S. V., & Nutt, D. J. (2013). Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression? Journal of Psychopharmacology, 27(10), 869-877. https://doi.org/10.1177/0269881113494104
Barkus, E. (2021). The effects of anhedonia in social context. Current Behavioral Neuroscience Reports, 8(3), 77-89. https://doi.org/10.1007/s40473-021-00232-x
Beard, C., Millner, A. J., Forgeard, M. J., Fried, E. I., Hsu, K. J., Treadway, M. T., Leonard, C. V., Kertz, S. J., & Björgvinsson, T. (2016). Network analysis of depression and anxiety symptom relationships in a psychiatric sample. Psychological Medicine, 46(16), 3359-3369. https://doi.org/10.1017/s0033291716002300
Bekhbat, M., Treadway, M. T., & Felger, J. C. (2022). Inflammation as a pathophysiologic pathway to anhedonia: Mechanisms and therapeutic implications. Current Topics in Behavioral Neurosciences, 58, 397-419. https://doi.org/10.1007/7854_2021_294
Bonhof, C. S., van de Poll-Franse, L. V., de Hingh, I., Nefs, G., Vreugdenhil, G., & Mols, F. (2021). Association between peripheral neuropathy and sleep quality among colorectal cancer patients from diagnosis until 2-year follow-up: Results from the s registry. Journal of Cancer Survivorship, 17, 1-12.
Borsini, A., Wallis, A. S. J., Zunszain, P., Pariante, C. M., & Kempton, M. J. (2020). Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression. Cognitive, Affective, & Behavioral Neuroscience, 20(4), 816-841. https://doi.org/10.3758/s13415-020-00804-6
Calderon, C., Carmona-Bayonas, A., Jara, C., Beato, C., Mediano, M., Ramón, Y. C. T., Carmen Soriano, M., & Jiménez-Fonseca, P. (2019). Emotional functioning to screen for psychological distress in breast and colorectal cancer patients prior to adjuvant treatment initiation. European Journal of Cancer Care, 28(3), e13005. https://doi.org/10.1111/ecc.13005
Chou, A. F., Stewart, S. L., Wild, R. C., & Bloom, J. R. (2012). Social support and survival in young women with breast carcinoma. Psychooncology, 21(2), 125-133. https://doi.org/10.1002/pon.1863
Collin, L. J., Veres, K., Gradus, J. L., Ahern, T. P., Lash, T. L., & Sørensen, H. T. (2022). Preexisting stress-related diagnoses and mortality: A Danish cancer cohort study. Cancer, 128(6), 1312-1320. https://doi.org/10.1002/cncr.34036
Davidson, K. W., Burg, M. M., Kronish, I. M., Shimbo, D., Dettenborn, L., Mehran, R., Vorchheimer, D., Clemow, L., Schwartz, J. E., Lespérance, F., & Rieckmann, N. (2010). Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Archives of General Psychiatry, 67(5), 480-488. https://doi.org/10.1001/archgenpsychiatry.2010.36
Doyle, F., Conroy, R., & McGee, H. (2012). Differential predictive value of depressive versus anxiety symptoms in the prediction of 8-year mortality after acute coronary syndrome. Psychosomatic Medicine, 74(7), 711-716. https://doi.org/10.1097/PSY.0b013e318268978e
DSM-5™. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596
Farkas, I., Ábel, D., Palla, G., & Vicsek, T. (2007). Weighted network modules. New Journal of Physics, 9(6), 180. https://doi.org/10.1088/1367-2630/9/6/180
Fried, E. I., Epskamp, S., Nesse, R. M., Tuerlinckx, F., & Borsboom, D. (2016). What are 'good' depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. Journal of Affective Disorders, 189, 314-320. https://doi.org/10.1016/j.jad.2015.09.005
Fried, E. I., & Nesse, R. M. (2015). Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. Journal of Affective Disorders, 172, 96-102. https://doi.org/10.1016/j.jad.2014.10.010
Friedman, J., Hastie, T., & Tibshirani, R. (2008). Sparse inverse covariance estimation with the graphical lasso. Biostatistics, 9(3), 432-441. https://doi.org/10.1093/biostatistics/kxm045
Greten, F. R., & Grivennikov, S. I. (2019). Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 51(1), 27-41. https://doi.org/10.1016/j.immuni.2019.06.025
Hendriks, C., Drent, M., Elfferich, M., & De Vries, J. (2018). The fatigue assessment scale: Quality and availability in sarcoidosis and other diseases. Current Opinion in Pulmonary Medicine, 24(5). https://journals.lww.com/co-pulmonarymedicine/Fulltext/2018/09000/The_Fatigue_Assessment_Scale__quality_and.14.aspx, 495-503.
Hinnen, C., & Mols, F. (2022). Fluctuations in core depressive symptoms in colorectal cancer patients. A prospective, population-based PROFILES-registry study. Psychology & Health, 13, 1-17. https://doi.org/10.1080/08870446.2022.2155670
Hubley, A. M. (2020). Beck depression inventory. In F. Maggino (Ed.), Encyclopedia of quality of life and well-being research (pp. 1-11). Springer International Publishing. https://doi.org/10.1007/978-3-319-69909-7_156-2
Kalin, N. H. (2020). The critical relationship between anxiety and depression. The American Journal of Psychiatry, 177(5), 365-367. https://doi.org/10.1176/appi.ajp.2020.20030305
Langvik, E., Hjemdal, O., & Nordahl, H. M. (2016). Personality traits, gender differences and symptoms of anhedonia: What does the hospital anxiety and depression scale (HADS) measure in nonclinical settings? Scandinavian Journal of Psychology, 57(2), 144-151. https://doi.org/10.1111/sjop.12272
Leventhal, A. M. (2012). Relations between anhedonia and physical activity. American Journal of Health Behavior, 36(6), 860-872. https://doi.org/10.5993/ajhb.36.6.12
Lidington, E., Giesinger, J. M., Janssen, S. H. M., Tang, S., Beardsworth, S., Darlington, A.-S., Starling, N., Szucs, Z., Gonzalez, M., Sharma, A., Sirohi, B., van der Graaf, W. T. A., & Husson, O. (2022). Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer. Quality of Life Research., 31, 2717-2727. https://doi.org/10.1007/s11136-022-03139-6
Liu, Z. Y., Wang, C., Zhang, Y. J., & Zhu, H. L. (2022). Combined lifestyle, mental health, and mortality in US cancer survivors: A national cohort study. Journal of Translational Medicine, 20(1), 376. https://doi.org/10.1186/s12967-022-03584-4
Maunsell, E., Brisson, J., & Deschênes, L. (1995). Social support and survival among women with breast cancer. Cancer, 76, 631-637.
Mehta, N. D., Stevens, J. S., Li, Z., Gillespie, C. F., Fani, N., Michopoulos, V., & Felger, J. C. (2020). Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women. Social Cognitive and Affective Neuroscience, 15(10), 1046-1055. https://doi.org/10.1093/scan/nsz100
Michielsen, H. J., De Vries, J., & Van Heck, G. L. (2003). Psychometric qualities of a brief self-rated fatigue measure: The fatigue assessment scale. Journal of Psychosomatic Research, 54(4), 345-352. https://doi.org/10.1016/s0022-3999(02)00392-6
Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews. Immunology, 16(1), 22-34. https://doi.org/10.1038/nri.2015.5
Mols, F., Husson, O., Roukema, J. A., & van de Poll-Franse, L. V. (2013). Depressive symptoms are a risk factor for all-cause mortality: Results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. Journal of Cancer Survivorship, 7(3), 484-492. https://doi.org/10.1007/s11764-013-0286-6
Pinquart, M., & Duberstein, P. R. (2010). Depression and cancer mortality: A meta-analysis. Psychological Medicine, 40(11), 1797-1810. https://doi.org/10.1017/S0033291709992285
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401. https://doi.org/10.1177/014662167700100306
Schroevers, M. J., Sanderman, R., van Sonderen, E., & Ranchor, A. V. (2000). The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and positive affect in cancer patients and healthy reference subjects. Quality of Life Research, 9(9), 1015-1029. https://doi.org/10.1023/a:1016673003237
Smith, A. B., Selby, P. J., Velikova, G., Stark, D., Wright, E. P., Gould, A., & Cull, A. (2002). Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychology and Psychotherapy, 75(Pt 2), 165-176. https://doi.org/10.1348/147608302169625
Solms, M. (2012). Depression: A neuropsychoanalytic perspective. International Forum of Psychoanalysis, 21(3-4), 207-213. https://doi.org/10.1080/0803706X.2011.631582
Spinhoven, P., Ormel, J., Sloekers, P. P., Kempen, G. I., Speckens, A. E., & Van Hemert, A. M. (1997). A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychological Medicine, 27(2), 363-370.
Szczypiński, J. J., & Gola, M. (2018). Dopamine dysregulation hypothesis: The common basis for motivational anhedonia in major depressive disorder and schizophrenia? Reviews in the Neurosciences, 29(7), 727-744. https://doi.org/10.1515/revneuro-2017-0091
Tan, M., Shallis, A., & Barkus, E. (2020). Social anhedonia and social functioning: Loneliness as a mediator. PsyCh Journal, 9(2), 280-289. https://doi.org/10.1002/pchj.344
Thomsen, K. R. (2015). Measuring anhedonia: Impaired ability to pursue, experience, and learn about reward. Frontiers in Psychology, 6, 1409. https://doi.org/10.3389/fpsyg.2015.01409
Tian, F., Fang, F., Shen, Q., Ye, W., Valdimarsdóttir, U. A., & Song, H. (2022). Stress-related disorders and subsequent cancer risk and mortality: A population-based and sibling-controlled cohort study in Sweden. European Journal of Epidemiology, 37(9), 947-958. https://doi.org/10.1007/s10654-022-00898-x
Tissier, R., Houwing-Duistermaat, J., & Rodríguez-Girondo, M. (2018). Improving stability of prediction models based on correlated omics data by using network approaches. PLoS One, 13(2), e0192853. https://doi.org/10.1371/journal.pone.0192853
Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews, 35(3), 537-555. https://doi.org/10.1016/j.neubiorev.2010.06.006
van de Poll-Franse, L. V., Horevoorts, N., van Eenbergen, M., Denollet, J., Roukema, J. A., Aaronson, N. K., Vingerhoets, A., Coebergh, J. W., de Vries, J., Essink-Bot, M. L., & Mols, F. (2011). The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. European Journal of Cancer, 47(14), 2188-2194. https://doi.org/10.1016/j.ejca.2011.04.034
van Eeden, W. A., van Hemert, A. M., Carlier, I. V. E., Penninx, B., Lamers, F., Fried, E. I., Schoevers, R., & Giltay, E. J. (2020). Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression. Translational Psychiatry, 10(1), 235. https://doi.org/10.1038/s41398-020-00920-4
van Roekel, E., Heininga, V. E., Vrijen, C., Snippe, E., & Oldehinkel, A. J. (2019). Reciprocal associations between positive emotions and motivation in daily life: Network analyses in anhedonic individuals and healthy controls. Emotion, 19(2), 292-300. https://doi.org/10.1037/emo0000424
Vijayvergia, N., & Denlinger, C. S. (2015). Lifestyle factors in cancer survivorship: Where we are and where we are headed. Journal of Personalized Medicine, 5(3), 243-263. https://doi.org/10.3390/jpm5030243
Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z. (2020). Prognostic value of depression and anxiety on breast cancer recurrence and mortality: A systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry, 25(12), 3186-3197. https://doi.org/10.1038/s41380-020-00865-6
Watt, D. F., & Panksepp, J. (2009). Depression: An evolutionarily conserved mechanism to terminate separation distress? A review of aminergic, Peptidergic, and neural network perspectives. Neuropsychoanalysis, 11(1), 7-51. https://doi.org/10.1080/15294145.2009.10773593
Wu, Z., Nguyen, N. H., Wang, D., Lynch, B. M., Hodge, A. M., Bassett, J. K., White, V. M., Borland, R., English, D. R., Milne, R. L., Giles, G. G., & Dugué, P. A. (2020). Social connectedness and mortality after prostate cancer diagnosis: A prospective cohort study. International Journal of Cancer, 147(3), 766-776. https://doi.org/10.1002/ijc.32786
Zellner, M. R., Watt, D. F., Solms, M., & Panksepp, J. (2011). Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: Why depression feels so bad and what addicts really want. Neuroscience and Biobehavioral Reviews, 35(9), 2000-2008. https://doi.org/10.1016/j.neubiorev.2011.01.003
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021). Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduction and Targeted Therapy, 6(1), 263. https://doi.org/10.1038/s41392-021-00658-5
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361-370. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6880820